SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-012200
Filing Date
2020-02-24
Accepted
2020-02-24 18:39:46
Documents
1
Period of Report
2020-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6458
  Complete submission text file 0001209191-20-012200.txt   7982
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Issuer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN ST, WEIZMANN SCIENCE PARK REHOVOT L3 7670402
Business Address
Wiley Matthew T. (Reporting) CIK: 0001759703 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36621 | Film No.: 20646410